News Preview
AnaptysBio: Fully Valued; With Major Litigation Uncertainty
AnaptysBio is fully valued, with major litigation uncertainty weighing on its stock price.
The company's recent results and growth prospects have led analysts to maintain a neutral rating on the stock.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.